OÜ PharmaMintRegistered
Key figures
6 285 855 €+49,3%
Revenue 2025
+111,7%
Average annual growth 2020–2025
Ratios
2025−9,2%
Profit margin
−4,4%
EBITDA margin
−468,3%
Equity ratio
0,2×
Current ratio
11,5%
Return on equity
2158 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 2 478 605 € | 20 | 68 491 € |
| Q1 2026 | 2 021 754 € | 19 | 97 955 € |
| Q4 2025 | 2 327 342 € | 18 | 69 576 € |
| Q3 2025 | 1 418 472 € | 18 | 70 176 € |
| Q2 2025 | 1 917 784 € | 17 | 63 179 € |
| Q1 2025 | 1 793 602 € | 17 | 76 891 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2020–2025
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||
| Total current assets | 119 581 | 735 126 | 706 420 | 555 253 | 744 459 | 1 036 384 |
| Total non-current assets | 25 784 | 65 707 | 47 871 | 38 730 | 37 493 | 36 819 |
| Total assets | 145 365 | 800 833 | 754 291 | 593 983 | 781 952 | 1 073 203 |
| Balance sheet — liabilities and equity | ||||||
| Current liabilities | 232 113 | 549 422 | 865 509 | 879 151 | 1 121 668 | 6 098 578 |
| Non-current liabilities | — | 1 050 000 | 1 700 000 | 2 950 000 | 4 110 000 | — |
| Total liabilities | 232 113 | 1 599 422 | 2 565 509 | 3 829 151 | 5 231 668 | 6 098 578 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | — | −89 248 | −801 089 | −1 813 718 | −3 237 668 | −4 452 216 |
| Profit for the year | −89 248 | −711 841 | −1 012 629 | −1 423 950 | −1 214 548 | −575 659 |
| Total equity | −86 748 | −798 589 | −1 811 218 | −3 235 168 | −4 449 716 | −5 025 375 |
| Income statement | ||||||
| Sales revenue | 147 699 | 1 115 315 | 2 298 326 | 2 657 259 | 4 209 578 | 6 285 855 |
| Operating profit | −89 249 | −690 601 | −957 891 | −1 263 860 | −956 146 | −296 798 |
| EBITDA | −86 953 | −675 349 | −940 054 | −1 244 982 | −938 351 | −275 293 |
| Profit before income tax | −89 248 | −711 841 | −1 012 629 | −1 423 950 | −1 214 548 | −575 659 |
| Profit for the reporting year | −89 248 | −711 841 | −1 012 629 | −1 423 950 | −1 214 548 | −575 659 |
| Labour costs | 56 640 | 156 537 | 153 335 | 424 782 | 540 363 | 747 115 |
| Depreciation of non-current assets | 2296 | 15 252 | 17 837 | 18 878 | 17 795 | 21 505 |
| Other indicators | ||||||
| Employees | 4 | 7 | 7 | 14 | 16 | 19 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Ravimite jaemüük